Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

2151 - 2160 of 3883 results found

Management der Urethritis bei männlichen Jugendlichen und Erwachsenen. S3-LL (DDG, DSTIG)

MeSH Terms

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
Management of urethritis in male adolescents and adults
Keywords
Urethritiden, Urethritis, Entzündung, urethrale Mukosa,Harnröhrenentzündung, Harnröhre, sexuell übertragbare Krankheiten, Infektion
Date for Review
30/09/2029
Publication Scope
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2025

Management des systemischen Lupus erythematodes mit sekundärem Antiphospholipid-Syndrom, Kinderwunsch und Schwangerschaft. S3-LL (DGRh)

MeSH Terms

Lupus Erythematosus; Systemic (C17.300.480); Lupus Erythematosus; Systemic (C20.111.590)

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
Management of systemic lupus erythematosus with secondary antiphospholipid syndrome, fertility, and pregnancy
Keywords
Systemischer Lupus erythematodes, Lupusnephritis, Antiphospholipid-Syndrom, Schwangerschaft, systemic lupus erythematosus, lupusnephritis, antiphospholipid syndrome, pregnancy, Systemischer Lupus erythematodes, Lupus erythematodes disseminatus, LED, systemic lupus erythematosus
Date for Review
31/03/2030
Publication Date
04/04/2025
Publication Scope
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2025

Management erwachsener Patienten mit Bronchiektasen-Erkrankung. S2k-LL (DGP)

MeSH Terms

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
Management of adult patients with bronchiectasis disease
Keywords
Bronchiektasen, J47, Lungenerkrankung, Bronchus, Lunge, Bronchen, Allergische bronchopulmonale Aspergillose (ABPA), Chronische pulmonale Aspergillose (CPA), Aspergillustracheobronchitis (ATB), Asthma, Chronische obstruktive Lungenerkrankung (COPD), Tuberkulose (TB), Lungenerkrankung durch nichttuberkulöse Mykobakterien (NTM), Primäre Ciliäre Dyskinesie (PCD), Kartagener Syndrom, Rheumatoide Arthritis, Sjögren-Syndrom, Alpha-1-Antitrypsinmangel,Primäre Immundefekte, Mukoviszidose bzw. Cystische Fibrose (CF)
Date for Review
27/05/2029
Publication Date
29/05/2024
Expected Publication Date
31/03/2024
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2024

Management IgE-vermittelter Nahrungsmittelallergien. S2k-LL (DGAKI)

MeSH Terms

Allergy and Immunology (H02.403.044)

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
Management of IgE-mediated food allergies
Keywords
Nahrungsmittelallergie, IgE-Diagnostik, Provokationstestung, Ernährungsberatung, Therapie, food allergy, IgE diagnostics, provocation testing, nutritional counseling, therapy, T78.0, T78.1, L27.2, L23.6, T78.2
Date for Review
31/12/2026
Publication Date
25/02/2022
Publication Scope
assessment
management
Countries of Application
Germany
Guideline Publication Status
Under Review
Languages
German
Authors
AWMF (DE)
Publication Year
2022

Management of Acne

MeSH Terms
Acneiform Eruptions (C17.800.030)
Date for Review
30/01/2016
Publication Scope
management
Countries of Application
Malaysia
Guideline Publication Status
Published
Languages
English
Authors
HTA DoH (MY)
Publication Year
2012

Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians

MeSH Terms

Gout (C05.550.114.423); Gout (C05.799.414); Gout (C16.320.565.798.368); Gout (C18.452.648.798.368); Uricosuric Agents (D27.505.954.329.337.900); Gout Suppressants (D27.505.954.329.337); Therapeutic Uses (D27.505.954); Pharmacologic Actions (D27.505); Anti-Inflammatory Agents; Non-Steroidal (D27.505.696.663.850.014.040.500); Anti-Inflammatory Agents; Non-Steroidal (D27.505.954.158.030); Anti-Inflammatory Agents; Non-Steroidal (D27.505.954.329.030); Steroids (D04.808); Xanthine Oxidase (D08.811.682.047.928); Allopurinol (D03.438.759.160); Colchicine (D03.132.225); Prednisolone (D04.808.745.432.769.795); Ibuprofen (D02.241.223.701.430); Naproxen (D02.455.426.559.847.638.472.500); Naproxen (D04.615.638.472.450); Diclofenac (D02.241.223.601.210); Indomethacin (D03.438.473.420); Cyclooxygenase 2 Inhibitors (D27.505.519.389.310.500); Cyclooxygenase 2 Inhibitors (D27.505.696.663.850.014.040.500.500.500); Cyclooxygenase 2 Inhibitors (D27.505.954.158.030.500.500); Cyclooxygenase 2 Inhibitors (D27.505.954.329.030.500.500); Methylprednisolone (D04.808.745.432.769.795.539); Probenecid (D02.065.884.625); Probenecid (D02.886.590.700.625)

Guideline Contact
Amir Qaseem ([email protected])
Publication Date
11/01/2016
Date of Last Evidence Search
03/2016
Methods Applied
See Publication
Publication Scope
Treatment, management
Countries of Application
United States
Guideline Publication Status
Inactive
Languages
English
Authors
ACP (US)
Publication Year
2016

Management of acute deltoid ligament inury in ankle fracture

MeSH Terms

group of mesh terms

Guideline Contact
Najeeb Bsoul [email protected]
Keywords
acute, deltoid, ligament, injury, ankle, fracture, managment
Publication Date
2026
Methods Applied
based on AGREE II and NICE manual
Publication Scope
Management
Countries of Application
International
Guideline Publication Status
Development
Languages
English
Authors
Group of experts from Tsinghua University, Beijing Jishuitan Hospital, other hospital in china, and international experts
Willingness to Collaborate
Yes